Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Leflunomide is more likely to help treat alopecia areata than cause it.

Trichoscopy can help diagnose and assess disease activity in connective tissue diseases by identifying specific hair and scalp signs.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Many patients on methotrexate experience significant side effects but still continue the medication.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Lupus severely affects daily life, work, and mental health, with many experiencing frequent flares and medication side-effects.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Secukinumab can cause hair loss, which may improve after stopping the medication.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

A woman was wrongly diagnosed with lupus but actually had leprosy.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

A(1-7) treatment reduces symptoms of lupus in mice.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.